eFFECTOR Therapeutics (EFTR) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
eFFECTOR Therapeutics, Inc. has received confirmation from Nasdaq that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. This follows a prior notification of non-compliance due to the company’s stock failing to meet the minimum bid price over a 30-day period. With this issue resolved, the matter is now considered closed by Nasdaq.
For further insights into EFTR stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.